Search research articles
Contact Us
Filters
Showing results (41-50 of 73) with videos related to
Page
of 8
Sort By:
International Journal of Urology : Official Journal of the Japanese Urological Association
|
December 27, 2023
The clinical impact of ureteroscopy for upper tract urothelial carcinoma: A multicenter study
Juria Nakano, Fumihiko Urabe, Yuria Kiuchi, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
October 13, 2023
Prognostic significance of subclassifying pathological T3 upper tract urothelial carcinoma: Results from a multicenter cohort study
Yushi Suhara, Fumihiko Urabe, Kentaro Yoshihara, et al.
Clinical Genitourinary Cancer
|
May 10, 2025
Optimal Cystoscopic Surveillance Schedule Following Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma
Yuhei Koike, Fumihiko Urabe, Katsuki Muramoto, et al.
Japanese Journal of Clinical Oncology
|
January 25, 2026
Tumor cell invasion of blood vessels predicts poor survival in upper tract urothelial carcinoma following radical nephroureterectomy
Miyaka Umemori, Shun Sato, Fumihiko Urabe, et al.
Japanese Journal of Clinical Oncology
|
November 19, 2025
Safety profile of enfortumab vedotin plus pembrolizumab in locally advanced or metastatic urothelial carcinoma: a multicenter Japanese cohort study
Kosuke Iwatani, Fumihiko Urabe, Keiichiro Mori, et al.
Urologic Oncology
|
March 1, 2025
Locations of metastases in and oncological outcomes of patients with metastatic castration-sensitive prostate cancer: Real-world data from a multicenter study
Fumihiko Urabe, Kojiro Tashiro, Katsuki Muramoto, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
July 20, 2024
Changes in the treatment landscape of metastatic hormone-sensitive prostate cancer following approval of upfront androgen receptor signaling inhibitors: A multicenter study
Fumihiko Urabe, Katsuki Muramoto, Takafumi Yanagisawa, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
May 16, 2025
Evaluation of Optimal Sequential Treatment Patterns and Clinical Outcomes in Patients With Advanced Urothelial Carcinoma Treated With First-Line Platinum-Based Chemotherapy: A Multicenter Collaborative Study
Fumihiko Urabe, Kojiro Tashiro, Yu Imai, et al.
The Prostate
|
April 9, 2025
Evaluating CRPC Definition: Comparing Upfront ARSI and Conventional Hormonal Therapy for Metastatic Hormone Sensitive Prostate Cancer (mHSPC) in Real World Propensity Score Matched Cohort
Tatsuya Shimomura, Fumihiko Urabe, Katsuki Muramoto, et al.
Japanese Journal of Clinical Oncology
|
January 17, 2025
Clinical outcomes and treatment patterns of maintenance avelumab in locally advanced or metastatic urothelial carcinoma: a multicenter collaborative study
Yuki Taneda, Fumihiko Urabe, Naoki Uchida, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 73) with videos related to
Sort By:
Page
of 8
International Journal of Urology : Official Journal of the Japanese Urological Association
|
December 27, 2023
The clinical impact of ureteroscopy for upper tract urothelial carcinoma: A multicenter study
Juria Nakano, Fumihiko Urabe, Yuria Kiuchi, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
October 13, 2023
Prognostic significance of subclassifying pathological T3 upper tract urothelial carcinoma: Results from a multicenter cohort study
Yushi Suhara, Fumihiko Urabe, Kentaro Yoshihara, et al.
Clinical Genitourinary Cancer
|
May 10, 2025
Optimal Cystoscopic Surveillance Schedule Following Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma
Yuhei Koike, Fumihiko Urabe, Katsuki Muramoto, et al.
Japanese Journal of Clinical Oncology
|
January 25, 2026
Tumor cell invasion of blood vessels predicts poor survival in upper tract urothelial carcinoma following radical nephroureterectomy
Miyaka Umemori, Shun Sato, Fumihiko Urabe, et al.
Japanese Journal of Clinical Oncology
|
November 19, 2025
Safety profile of enfortumab vedotin plus pembrolizumab in locally advanced or metastatic urothelial carcinoma: a multicenter Japanese cohort study
Kosuke Iwatani, Fumihiko Urabe, Keiichiro Mori, et al.
Urologic Oncology
|
March 1, 2025
Locations of metastases in and oncological outcomes of patients with metastatic castration-sensitive prostate cancer: Real-world data from a multicenter study
Fumihiko Urabe, Kojiro Tashiro, Katsuki Muramoto, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
July 20, 2024
Changes in the treatment landscape of metastatic hormone-sensitive prostate cancer following approval of upfront androgen receptor signaling inhibitors: A multicenter study
Fumihiko Urabe, Katsuki Muramoto, Takafumi Yanagisawa, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
May 16, 2025
Evaluation of Optimal Sequential Treatment Patterns and Clinical Outcomes in Patients With Advanced Urothelial Carcinoma Treated With First-Line Platinum-Based Chemotherapy: A Multicenter Collaborative Study
Fumihiko Urabe, Kojiro Tashiro, Yu Imai, et al.
The Prostate
|
April 9, 2025
Evaluating CRPC Definition: Comparing Upfront ARSI and Conventional Hormonal Therapy for Metastatic Hormone Sensitive Prostate Cancer (mHSPC) in Real World Propensity Score Matched Cohort
Tatsuya Shimomura, Fumihiko Urabe, Katsuki Muramoto, et al.
Japanese Journal of Clinical Oncology
|
January 17, 2025
Clinical outcomes and treatment patterns of maintenance avelumab in locally advanced or metastatic urothelial carcinoma: a multicenter collaborative study
Yuki Taneda, Fumihiko Urabe, Naoki Uchida, et al.
Page
of 8